The neuroprotective transcription factor nuclear receptor related 1 (Nurr1, NR4A2) is in the focus of biomedical research for its promising neuroprotective role in Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis. Here, NR4A2 is linked to early-onset autosomal dominant Alzheimer disease.